1 results match your criteria: "Japan. Electronic address: arakawa.m@yashio-central-hospital.jp.[Affiliation]"
Efficacy of liraglutide as a follow-up therapy after resolution of glucotoxicity with intensive insulin therapy.
Diabetes Metab Syndr
August 2014
Yashio Central General Hospital, 1-41-3 Midoricho, Yashio, Saitama 340-0808, Japan. Electronic address:
Objective: To assess the utility of liraglutide, a GLP-1 receptor agonist, as additional therapy following resolution of glucotoxicity with insulin therapy.
Methods: The subjects were 13 Japanese patients with short-duration type 2 diabetes mellitus (2.0 ± 2.